Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-13T05:56:05.495Z Has data issue: false hasContentIssue false

Eye-movements deficits in schizophrenia: A metanalysis of evidence

Published online by Cambridge University Press:  13 August 2021

M. Orsoni
Affiliation:
Department Of Psychology, University of Bologna, Cesena, Italy
S. Dal Col
Affiliation:
Department Of Psychology, University of Bologna, Cesena, Italy
C. Ruscelli
Affiliation:
Department Of Psychology, University of Bologna, Cesena, Italy
R. Sant’Angelo*
Affiliation:
Mental Health Department, AUSL ROMAGNA, Cesena, Italy
M. Benassi
Affiliation:
Department Of Psychology, University of Bologna, Cesena, Italy
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Although eye-movement disorders are one of the most replicated deficits in the psychiatric literature, the strong heterogeneity of results is still an unexplained issue that could be effectively addressed with a quantitative review of evidence.

Objectives

For this reason, a large-scale metanalytic study comprising more than 200 studies was conducted to analyse the presence of eye-movement deficits in schizophrenia patients, as compared to healthy controls.

Methods

To this aim, saccadic eye movements were grouped based on the type of task required (e.g., standard, predictive) and the quantification method used (e.g., number, duration, amplitude). For each sub-group separate meta-analysis were computed. Cohen’s d was used as measure of effect size. Risk of bias within and between studies and heterogeneity were also analysed.

Results

indicated low Cohen’s d with the exception of the number of correct antisaccades – where schizophrenia patients reportedless correct anti-saccadesthan healthy controls - and antisaccades error rate – where schizophrenia patients reported a higher number of errors than healthy controls.

Conclusions

Antisaccades emerged as better suited to differentiate between patients and healthy controls, thus making them the most promising candidate as a possible biomarker for schizophrenia.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.